The loss of PNPLA3-mediated TG hydrolase activity in this variant is not sufficient to induce hepatic steatosis, since Pnpla3−/− mice did not show fatty liver disease [24]. The gene discussed is PNPLA3; the disease is Hepatic steatosis.